Valuation: UMeWorld Inc.

Market Cap 134M 118M 111M 101M 190M 12.81B 191M 1.34B 515M 6.54B 501M 490M 21.05B P/E 2024
-198x
P/E 2025 -174x
Enterprise Value 133M 118M 111M 101M 189M 12.8B 191M 1.34B 515M 6.53B 501M 490M 21.03B EV / Sales 2024
47,388x
EV / Sales 2025 20,593x
Free-Float
25.44%
Yield 2024 *
-
Yield 2025 -
1 day+7.84%
1 week-52.17%
Current month-52.17%
1 month-52.17%
3 months-45.00%
6 months-15.38%
Current year+52.78%
1 week 0.55
Extreme 0.55
1.15
1 month 0.55
Extreme 0.55
1.15
Current year 0.4
Extreme 0.4
1.25
1 year 0.36
Extreme 0.36
1.25
3 years 0.2
Extreme 0.2
1.25
5 years 0.07
Extreme 0.07
1.25
10 years 0
Extreme 0
1.25
Date Insider Type Main position Quantity % Market Cap. Importance
7/6/26 Sell

Chief Financial Officer

-10,000 0.0086%
4/14/26 Other

Chief Financial Officer

1,663,834 1.4393%
1/21/26 Other

Director

1,380,131 1.3204%
Change 5-day change 1-year change 3-year change Capi.($)
+7.84%-52.17%+37.50%+22.22% 134M
+0.33%-1.44%+17.56%+43.59% 10.4B
+0.21%-1.26%+19.85%+18.05% 7.24B
-0.45%-9.70%+170.91%+188.39% 5.44B
-2.58%-2.47%-25.39%-7.97% 4.88B
-0.89%-6.28%+36.77%+177.99% 4.82B
0.00%-3.03%+8.47%+18.52% 3.17B
-0.94%-13.58%+85.84%+265.22% 2.88B
-2.76%-10.60%+15.82%+237.39% 2.2B
+0.18%+0.18%+47.83%+106.84% 1.29B
Average +0.09%-3.65%+41.52%+107.02% 4.24B
Weighted average by Cap. -0.52%-3.70%+39.68%+92.16%

Financials

2024 2025
Net sales 941 830.43 785.72 712.56 1.34K 90.3K 1.35K 9.43K 3.63K 46.11K 3.53K 3.46K 148K 2.22K 1.96K 1.86K 1.68K 3.15K 213K 3.19K 22.26K 8.58K 109K 8.34K 8.16K 350K
Net income -224K -198K -187K -170K -319K -21.54M -322K -2.25M -867K -11M -843K -825K -35.39M -258K -228K -216K -196K -367K -24.77M -370K -2.59M -997K -12.65M -969K -948K -40.71M
Net Debt -122K -107K -102K -92.24K -173K -11.69M -175K -1.22M -470K -5.97M -457K -447K -19.21M -155K -137K -130K -118K -221K -14.92M -223K -1.56M -600K -7.62M -584K -571K -24.52M
Logo UMeWorld Inc.
UMeWorld Inc. is a holding company focused on functional nutrition and health and wellness products. The Company owns diacylglycerol (DAG)-based cooking oil and related products marketed under the DAGola brand through its wholly owned subsidiary, Dagola Inc. The Company’s two verticals are DAGola and Projet Verdant. DAGola is a functional nutrition platform pioneering clinically validated smart cooking oils. Its Verdant project is a lipid-to-fuel feedstock platform supplying refinery-compatible intermediates for the aviation and transportation sectors. It develops enzymatically upgraded lipid streams engineered for Hydroprocessed Esters and Fatty Acids (HEFA)-compatible Sustainable Aviation Fuel (SAF) pathways. Its platform enables conversion of low-grade waste lipids into high-purity, refinery-ready feedstock, delivering carbon intensity. The Company’s products are sold primarily through online marketplace platforms and direct-to-consumer channels in the United States.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. UMEW Stock